DHSE: Global Health: Sentinel Drug Testing FY26/27

This is not a call for competition, but an opportunity for DHSC to gather feedback, test market capability and capacity, refine the specification and procurement strategy, and identify any barriers to successful delivery.

DHSC intends to share draft requirement information and a preliminary market engagement questionnaire with interested suppliers. Feedback will be used to test the proposed service model, delivery timetable, performance standards, pricing approach and allocation of risk.

The objectives of the preliminary market engagement are to:

a) understand the breadth, capacity and maturity of the supplier market;

b) test whether the proposed service scope, sample volumes, turnaround times and mobilisation timetable are achievable;

c) understand viable delivery models, including consortium and subcontracting arrangements;

d) identify technical, operational, information-governance or commercial barriers; and

e) support a competitive, proportionate and deliverable procurement under the Procurement Act 2023.

Interested parties will be able to access the relevant documents through the Atamis system at health-family.force.com/s/Welcome ↗ using the project reference C473865

The PME Document provides further information on the project, proposed requirement and procurement approach, together with the response instructions and links to the relevant Microsoft Forms. Interested suppliers should review the documentation in Atamis and use the appropriate Microsoft Form in the PME Document to complete the questionnaire. Potential suppliers may also submit questions and comments on the proposed approach in accordance with the instructions in the PME Document.